Karin Steffens
Senior Investment Manager Zorg at Invest-NL- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Invest-NL
-
Netherlands
-
Financial Services
-
1 - 100 Employee
-
Senior Investment Manager Zorg
-
Jul 2021 - Present
Invest-NL is a private investment fund, financed with €1.7B by the Dutch State. Invest-NL invests in ventures, projects and other investment funds that drive the energy transition and/or accelerate the growth of innovative scale-ups. Investments range from €5M to €50M, in multiple investment rounds. Invest-NL is a private investment fund, financed with €1.7B by the Dutch State. Invest-NL invests in ventures, projects and other investment funds that drive the energy transition and/or accelerate the growth of innovative scale-ups. Investments range from €5M to €50M, in multiple investment rounds.
-
-
-
Key2Life
-
United States
-
Retail
-
Life Science Investment Specialist
-
Mar 2015 - Mar 2022
-
-
-
-
New Business Development Manager
-
Jul 2017 - Jun 2021
BioConnection is a Dutch based Contract Services and Manufacturing Organization. We are able to provide tailor-made solutions to bring your invention from the lab bench to the clinic and/or to the market. Our toolbox includes –among others- the following services: - Leasing of GMP cleanrooms (class A up to D; BSL2 if needed) - Manufacturing support for cell based therapies / ATMPs - Filling of complex formulations (e.g. microspheres, nanoparticles, liposomes) - Filling / freeze drying of peptides, proteins or small molecules (e.g. in vials, syringes); also small scale - Analytical development & validation Our own state-of-the-art GMP facility in Oss, The Netherlands, has an excellent manufacturing and regulatory track record (including EMA and US-FDA). Show less
-
-
-
Brabantse Ontwikkelings Maatschappij (BOM)
-
Netherlands
-
Government Relations Services
-
1 - 100 Employee
-
Senior Investment Manager Life Sciences & Health
-
Mar 2014 - Mar 2015
-
-
-
Key2Bio
-
Netherlands
-
Financial Services
-
Director
-
Sep 2011 - Mar 2015
-
-
-
-
Co-founder en partner
-
2011 - Mar 2014
-
-
-
-
Senior Portfolio Manager Health Care
-
Nov 2004 - Sep 2011
-
-
-
-
Senior Analyst Biotechnology
-
2000 - 2004
Analyses of Biotech companies and shared responsibility for the management of the ABN Amro Biotechnology Fund as well as the ABN Amro Pharma Fund. Analyses of Biotech companies and shared responsibility for the management of the ABN Amro Biotechnology Fund as well as the ABN Amro Pharma Fund.
-
-
-
ABN AMRO
-
Netherlands
-
Financial Services
-
100 - 200 Employee
-
Manager Pension Desk
-
1999 - 2000
-
-
Education
-
Vrije Universiteit Amsterdam (VU Amsterdam)
PhD, Molecular Biology and Biochemistry -
Vrije Universiteit Amsterdam (VU Amsterdam)
Drs, Chemistry -
Hermann Wesselink College